1. Home
  2. MIRM vs DORM Comparison

MIRM vs DORM Comparison

Compare MIRM & DORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$79.34

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Logo Dorman Products Inc.

DORM

Dorman Products Inc.

HOLD

Current Price

$123.65

Market Cap

4.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
DORM
Founded
2018
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.3B
IPO Year
2019
1991

Fundamental Metrics

Financial Performance
Metric
MIRM
DORM
Price
$79.34
$123.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
4
Target Price
$92.45
$180.50
AVG Volume (30 Days)
809.5K
182.2K
Earning Date
11-04-2025
10-27-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.49
EPS
N/A
8.03
Revenue
$471,794,000.00
$2,126,159,000.00
Revenue This Year
$53.78
$9.99
Revenue Next Year
$19.91
$5.25
P/E Ratio
N/A
$15.64
Revenue Growth
53.66
7.94
52 Week Low
$36.88
$106.95
52 Week High
$82.58
$166.89

Technical Indicators

Market Signals
Indicator
MIRM
DORM
Relative Strength Index (RSI) 62.33 36.02
Support Level $77.99 $124.38
Resistance Level $82.58 $128.88
Average True Range (ATR) 3.21 2.77
MACD 1.03 0.22
Stochastic Oscillator 83.25 6.52

Price Performance

Historical Comparison
MIRM
DORM

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About DORM Dorman Products Inc.

Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.

Share on Social Networks: